# Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors

> **NCT06133699** · NA · UNKNOWN · sponsor: **N.N. Petrov National Medical Research Center of Oncology** · enrollment: 44 (estimated)

## Conditions studied

- Testicular Germ Cell Tumor

## Interventions

- **PROCEDURE:** Orchofuniculectomy with simultaneous laparoscopic biopsy of the sentinel lymph node using indocyanine green dye with/without methylene blue dye.
- **DIAGNOSTIC_TEST:** Radiopharmaceutical administration (Technetium/methylene blue)

## Key facts

- **NCT ID:** NCT06133699
- **Lead sponsor:** N.N. Petrov National Medical Research Center of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-08
- **Primary completion:** 2024-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06133699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06133699, "Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06133699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*